COVID - 19 Vaccination Update - Day 487 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 17 MAY 2022 8:37 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 191.63 Crore (1,91,63,11,106) today. More than 13 lakh (13,09,721) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10406233
	2^nd Dose	10030869
	Precaution Dose	5050470
FLWs	1^st Dose	18417795
	2^nd Dose	17567604
	Precaution Dose	8238587
Age Group 12-14 years	1^st Dose	32083364
	2^nd Dose	12663031
Age Group 15-18 years	1^st Dose	59038939
	2^nd Dose	44239799
Age Group 18-44 years	1^st Dose	556666453
	2^nd Dose	485477004
	Precaution Dose	466256
Age Group 45-59 years	1^st Dose	203157157
	2^nd Dose	189800461
	Precaution Dose	1059107
Over 60 years	1^st Dose	127025201
	2^nd Dose	118317203
	Precaution Dose	16605573
Cumulative 1^st dose administered		1006795142
Cumulative 2^nd dose administered		878095971
Precaution Dose		31419993
Total		1916311106

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 17^th April, 2022 (487^th Day)
HCWs	1^st Dose	37
	2^nd Dose	500
	Precaution Dose	11228
FLWs	1^st Dose	65
	2^nd Dose	1197
	Precaution Dose	26352
Age Group 12-14 years	1^st Dose	170557
	2^nd Dose	290872
Age Group 15-18 years	1^st Dose	31776
	2^nd Dose	106474
Age Group 18-44 years	1^st Dose	35565
	2^nd Dose	312877
	Precaution Dose	23487
Age Group 45-59 years	1^st Dose	6485
	2^nd Dose	71234
	Precaution Dose	26497
Over 60 years	1^st Dose	5268
	2^nd Dose	49971
	Precaution Dose	139279
Cumulative 1^st dose administered		249753
Cumulative 2^nd dose administered		833125
Precaution Dose		226843
Total		1309721

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.